June 6, 2020 UMD Home FabLab AIMLab


Hydrogels

Hydrogels

 

The Fischell Department of Bioengineering research group is the first to use molecular imprinting to capture viruses. The patented technology shows promise in treating the H5N1 virus, the cause of the avian flu. It may also lead to new treatments for diabetes and more reliable vaccines. The concept shows great promise for a number of health care advances.

Called a "virus sponge," Professor Kofinas uses an inexpensive hydrogel to make an imprint of the target molecule and trap it as blood flows through the hydrogel. Kofinas sees a variety of cost-effective uses for the technology. He envisions machines similar to dialysis being used to remove viral infections from blood. Hepatitis and HIV could also be filtered from the blood.

Beyond viruses, Kofinas sees molecular imprinting being used in drugs and food additives to make life easier for diabetics by removing glucose. He also suggests using the technology in masks or protective clothing to prevent exposure to harmful biological agents.



May 8, 2007


«Previous Story  

 

 

Current Headlines

Pines: Stand in Solidarity, Unite Against Injustice

Promoting Diversity and Addressing Unconscious Bias

MSE Alum Awarded NSF Graduate Research Fellowship

UMD Researchers Design ‘Open’ Lithium-ion Battery

UMD Research Lab Receives ARO Grant to Investigate Reconfigurable Nanoparticle Assemblies

Two Engineers Among 2020-2021 Distinguished Scholar-Teachers

2020 Undergraduate Honors and Awards

Cleaning Natural Methane for Better Access to Renewable Energy

New, superfast method for ceramic manufacturing could open door to AI-driven materials discovery

Advance made towards next-generation rechargable batteries

 

Colleges A. James Clark School of Engineering
The College of Computer, Mathematical, and Natural Sciences

Communicate Contact Us
Contact the Webmaster
Google+
Follow us on TwitterTwitter logo

Links Privacy Policy
Sitemap
RSS

Copyright The University of Maryland University of Maryland
2004-2020